Auris Medical Provides Business Update and Reports First Half 2019 Financial Results
August 15, 2019 07:00 ET
|
Auris Medical AG
Hamilton, Bermuda, Aug. 15, 2019 (GLOBE NEWSWIRE) -- Enrollment of first patient in TRAVERS Phase 2 trial with AM-125 in acute vertigoEnrollment completed in Phase 1b trial with AM-201 in...
Wereldhave: PRESS RELEASE RESULTS FIRST HALF 2019
July 26, 2019 01:09 ET
|
Wereldhave N.V.
Direct result € 65.8m (H1 2018: € 59.7 from continuing operations) EPRA EPS € 1.44 (H1 2018: € 1.33 from continuing operations) Netherlands and Belgium solid performance, France challenging ...